Please assess the completion status of the following clinical trial:

Trial Title: Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Histologically or cytologically proven colorectal cancer~* Unresectable stage IV disease~* K-Ras wild type tumour~* Patients scheduled to undergo chemotherapy with irinotecan and cetuximab~Exclusion Criteria:~* Prior abdominal/pelvic radiotherapy, surgery or chemotherapy within 3 months prior to inclusion in the study~* Poorly controlled diabetes~* Concomitant serious illness, such as uncontrolled angina pectoris, myocardial infarction, heart failure, uncontrolled hypertension, infection~* Symptomatic brain metastases~* Pregnancy or participants of reproductive potential who are sexually active and not willing/able to use medically appropriate contraception

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PET-CT (Type: None): Patients with Unresectable stage IV colorectal cancer; eligible for 3rd line Irinotecan and Cetuximab

Based on this trial design, predict the completion outcome and termination type (if applicable).